Skip to main content

Legal signal newsroom

Life Sciences insights

Articles on life sciences law in China — practical guidance for foreign clients.

01Editorially selectedPractical impact before publishing order.
02Published vs updatedDates map to verified content fields.
03Bridge to evergreen researchInsights lead back to durable guides.

Archive dispatches

Latest legal signals

12 analyses on this page.

Life Sciences
Legally reviewed · 8 Aug 2026

Medical Representative Off-Label Push: When Manufacturer “Joint” Risk Becomes Real

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

CDMO Batch Failure in China: Who Pays for Destroyed Product, Delay, and Lost Launch Windows

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

CRO Enrollment Lag in China Trials: Drafting Liquidated Damages That Survive the Blame Game

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

CSO Marketing Fees in China Pharma: The Substance Test Before the Invoice Chain Burns You

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Black Box / Boxed Warnings in China: Why Strong Label Language Is Not Automatic Immunity

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

VBP Award Day +14: The Distributor Contract Heat-Map In-House Counsel Actually Needs

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Lock SaMD Intended Use Before the Growth Team Ships WeChat Claims

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

HGR Gate Before First-Patient-In: A Sponsor Checklist That Survives Global Protocols

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

FDA Warning Letter with a China Site: Run US CAPA and PRC Legal Tracks Together

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

One-Page Dawn Raid Card for Pharma Sales & Medical Affairs Teams

9 min readRead analysis →
Life Sciences
Legally reviewed · 6 Aug 2026

Cross-Border Medical Care for China-Connected Patients: Legal Risk Orientation

9 min readRead analysis →
Life Sciences
Legally reviewed · 3 Aug 2026

Drug Clinical Trial Data Compliance in China: The Fraud Red Line and Subject Protection

9 min readRead analysis →

Signal to framework

A development is useful only when you can place it in the wider legal framework.

Use the national guides for the durable architecture behind a news event, then return here when a development changes the practical question.

Explore legal guides →